US Stock MarketDetailed Quotes

REGN Regeneron Pharmaceuticals

Watchlist
  • 675.790
  • -18.850-2.71%
Close Jan 24 16:00 ET
  • 675.000
  • -0.790-0.12%
Post 20:01 ET
74.26BMarket Cap16.72P/E (TTM)

Regeneron Pharmaceuticals Key Stats

Regeneron Pharmaceuticals Q4 2024 Estimates Date

Currency:USDFeb 4, 2025

Estimate YoY
Revenue
3.76B
+9.56%
EPS
8.64
-15.23%
Buy

Jan 24, 2025

Regeneron Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 10 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.525B--
Feb 4, 20252024/Q4-- / 3.763B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 3.525B--
Feb 4, 20252024/Q4-- / 3.763B--
Oct 31, 20242024/Q33.721B / 3.667B--
Aug 1, 20242024/Q23.547B / 3.387B--
May 2, 20242024/Q13.145B / 3.221B--

Unlock Free Earnings Estimates

Regeneron Pharmaceuticals Earnings Reports

Read more

Trending Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Jan 24, 2025

Buy

  • Buy

    72.00%
  • Hold

    20.00%
  • Sell

    8.00%

Price Target

No Data